FendX Technologies
Nanotechnology surface coatings that repel harmful pathogens.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor investor | €0.0 | round | |
* | N/A | $710k | Private Placement non VC |
| Total Funding | 000k | ||
| CAD | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
FendX Technologies Inc. is a nanotechnology company, incorporated in 2020 and headquartered in Canada, that develops products to reduce the transmission of pathogens. The company's technology is licensed from McMaster University and was co-developed by researchers Dr. Leyla Soleymani and Dr. Tohid Didar. Dr. Carolyn Myers, a seasoned executive with over 30 years in the pharmaceutical industry, leads the company as President and CEO.
FendX is developing a portfolio of surface protection products, including films, sprays, and coatings for medical devices. The company's flagship product in development is REPELWRAP™ film, a protective surface coating designed to prevent the adhesion of bacteria, viruses, and liquids on high-touch surfaces. Inspired by the water-repellent properties of the lotus leaf, the technology uses a combination of microscopic surface texturing and chemistry to make surfaces omniphobic, or repellent to a wide range of contaminants. This repelling action is an alternative to antimicrobial technologies that kill pathogens, which can sometimes lead to microbial resistance.
The company is targeting its products for use in healthcare settings like hospitals and long-term care facilities, as well as other high-traffic areas such as public transportation and schools, to help control the spread of infections. Beyond the film, FendX is also developing a bifunctional spray coating designed to both repel and kill pathogens, and is exploring applications for its nanotechnology on medical devices like catheters to reduce biofilm formation and blockages. FendX operates on a partnership model for future manufacturing and distribution and is publicly traded on the Canadian Securities Exchange (CSE), the OTCQB, and the Frankfurt Stock Exchange (FSE).
Keywords: nanotechnology, pathogen repellent, surface coating, antimicrobial, infection control, REPELWRAP, medical device coating, hydrophilic surfaces, self-cleaning surfaces, pathogen transmission, disinfectant, healthcare-associated infections, high-touch surfaces, nano-coatings, bacteria repellent, virus repellent, lotus effect, omniphobic, McMaster University, surface contamination, biofilm prevention